KYMERA THERAPEUTICS INC

About

Kymera Therapeutics Inc. is a clinical-stage biotechnology company focused on discovering and developing novel small-molecule therapeutics. The company utilizes its proprietary Pegasus platform to advance a pipeline of degrader medicines designed to target and degrade disease-causing proteins. By focusing on protein degradation, Kymera aims to address significant unmet medical needs in immunology and oncology.